Penn Medicine Abramson Cancer Center
2023 Breast Cancer Highlights from International Medical Meetings: Fourth Annual Review
Penn Medicine Abramson Cancer Center
Updates for Locoregional Breast Cancer Management: 52 y/o Post-Menopausal Female
FEATURING
Alina Mateo
- 16 views
- October 23, 2023
Penn Medicine Abramson Cancer Center
Updates for Locoregional Breast Cancer Management: Focus on Radiation for Early BC
FEATURING
Neil Taunk
- 30 views
- October 23, 2023
Penn Medicine Abramson Cancer Center
Updates for TNBC & Hereditary Disease
FEATURING
Susan Domchek
- 43 views
- October 23, 2023
- 1
Penn Medicine Abramson Cancer Center
mTNBC: Which ADC and When?
FEATURING
Payal Shah
- 276 views
- October 23, 2023
- 1
Penn Medicine Abramson Cancer Center
HR+ Breast Cancer: A Case-Based Discussion - 38 y/o Premenopausal F With Grade 3 Left Disease
FEATURING
Rachel Jankowitz
- 113 views
- October 23, 2023
- 2
Penn Medicine Abramson Cancer Center
Updates for HR+ BC: Adjuvant CDK4/6i and MRD-Targeted Treatments
FEATURING
Angela DeMichele
- 184 views
- October 23, 2023
- 3
Penn Medicine Abramson Cancer Center
HR+ Breast Cancer: A Case-Based Discussion - 38 y/o Premenopausal F With mBC, ER+, HER2-
FEATURING
Rachel Jankowitz
- 88 views
- October 23, 2023
- 2
Penn Medicine Abramson Cancer Center
Neoadjuvant HER2+ BC: 46 y/o Female With 2.5cm Left-Sided Breast Mass
FEATURING
Ramy Sedhom
- 151 views
- October 22, 2023
Penn Medicine Abramson Cancer Center
Updates in HER2+ mBC: 47 y/o Female With Multiple Brain Mets
FEATURING
Meher Burki
- 121 views
- October 22, 2023